A side of chips

Advances in the science of microfluidics have led to a whole raft of novel devices. But due to considerations like complexity and cost, many of the teams behind the devices have been unable to produce them at scale. What are the major barriers to commercialisation, and what can be done to overcome them? Abi Millar finds out from Nikolaj Gadegaard, professor of biomedical engineering at the University of Glasgow, and Henne van Heeren, owner of enablingMNT.